Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis
Crossref DOI link: https://doi.org/10.1007/s12325-024-02858-1
Published Online: 2024-04-10
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Mei
Rupp, Loralee B.
Melkonian, Christina
Trudeau, Sheri
Daida, Yihe G.
Schmidt, Mark A.
Gordon, Stuart C.
Text and Data Mining valid from 2024-04-10
Version of Record valid from 2024-04-10
Article History
First Online: 10 April 2024